Merkel cell carcinoma and HIV infection.

February 9, 2002

Publisher

The Lancet Oncology

Publication Date

February 9, 2002

Authors

Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW

Download PDF

Abstract

Merkel cell carcinoma (MCC) is a rare skin cancer that occurs more frequently after organ transplantation or B-cell malignancy, conditions of suppressed or disordered immunity. To assess further whether immune suppression increases MCC risk, we studied its occurrence in a cohort of 309365 individuals with acquired immunodeficiency syndrome (AIDS) by using linked AIDS and cancer registries. We identified six cases of MCC, corresponding to a relative risk of 13.4 (95% CI 4.9-29.1) compared with the general population. These results suggest that immune suppression induced by the human immunodeficiency virus increases MCC risk.

View the clinical publication